Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer

Completed · Phase 2

Conditions studied: Ovarian Carcinoma, Primary Peritoneal Carcinoma

In brief

The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer

Key facts

Study ID

NCT00214058

Run by

University of Wisconsin, Madison

People needed

36

Starts

2002-08-01

Expected to finish

2006-02-01

Last updated by the study team

2019-11-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Recurrent ovarian or peritoneal cancer

You may not qualify if…

• No prior chemotherapy

Where it is running

• University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.